Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,235 total articles
Semiconductor-driven risk-off has pushed software multiples sharply lower in 2026. ServiceNow's revenue durability, a $29 billion backlog, improving technicals and falling short interest argue the stock may be forming a bottom. I am downgrading the rating to Hold given elevated valuation vs. secular macro risk, but propose a disciplined long trade:…
TeraWulf's pivot from pure Bitcoin mining to utility-grade AI hosting has meaningfully lowered revenue volatility and improved margin visibility. The 20-year, $19 billion Anthropic lease and proceeds from a $450M JV sale materially de-risk the company’s capital plan. At $15.59 the market capitalizes a business with an enterprise value near $10.45B …
CoreWeave's selloff has created an actionable entry on a company that is finally demonstrating the execution the market has been waiting for. With revenue accelerating (112% quarterly growth to $2.6B), a $100B+ backlog, improving operating performance, and technical momentum intact, we upgrade CRWV and recommend a long trade. The setup requires str…
Mercury General (MCY) has shifted from a cycle-era laggard to a structurally healthier auto insurer. Underwriting improvements and favorable reserve development have pushed the combined ratio well below 100%, producing a swing to profit and robust free cash flow. The stock trades at single-digit multiples and under 1x sales — attractive on the numb…
Salesforce is misunderstood today. The sell-off has priced in a world where AI agents commoditize CRM, but the company is executing a more defensible strategy: selling governed, data-connected AI labor inside its platform while aggressively returning capital. With $41.5B revenue, strong free cash flow ($14.7B) and a sizeable $27B buyback last quart…
Denali's FDA approval of Avlayah and the sale of a $195 million Rare Pediatric Disease Priority Review Voucher materially derisk near-term funding and validates the company's TransportVehicle platform. Despite a recent setback in a Parkinson's program, the combination of platform validation, improving cash runway, and low leverage argues for a bull…
Sandisk announced investor-day targets that include ~80% gross margins, ~75% operating margins and ~50% free cash flow margins. Those aren’t just optimistic aspirations - the company’s cash generation, lack of debt, and direct exposure to AI memory demand make a solid case that elevated margins can persist beyond a typical NAND cycle. This trade id…
Nvidia is benefiting from an elongating GPU cycle driven by generative AI adoption, higher ASPs, and tight supply dynamics. We upgrade to Strong Buy and recommend a long trade with a clear entry at $850.00, a stop at $720.00 and a target of $1,100.00 over a 180-trading-day horizon. The trade balances upside from continued data-center strength again…
Kenon (KEN) trades at $64.49 with a market cap of $3.36B and a generous $3.85 annual distribution. The stock offers a tradeable mid-term setup: buy the dividend yield and optionality from U.S. renewables + power assets that should benefit from rising data-center power demand. Entry at $64.50, stop $58.00, primary target $80.00 (mid-term) with upsid…
Kraken Robotics designs advanced underwater sensors, autonomous systems and data analytics for commercial and defense clients. A recent strategic acquisition and stronger defense spending create a tangible growth runway. The trade: accumulate on weakness with a tight stop and a multi-month horizon to capture contract cadence and product commerciali…
Blue Owl (OWL) has been punished with sector headlines and legal noise, but its cash-generation, $0.92 annualized distribution and attractive free-cash-flow yield support a tactical long. This trade idea lays out an entry at $11.60, a stop at $10.00 and a $16.00 target over a 180-trading-day horizon while highlighting the key risks to monitor.
Abbott has moved up from its May lows but remains attractive for investors focused on steady cash flow, margin resilience, and secular growth in diagnostics and chronic care. The balance sheet is healthy, free cash flow is meaningful at $7.82B, and the dividend yields roughly 2.25%. Valuation is no longer a deep value, but at a market cap of about …
Northeast Community Bancorp (NECB) looks like an attractive buy today: market cap ~$370M, P/E ~8.5 and P/B ~1.04, a raised quarterly dividend ($0.25) that lifts the yield to roughly 3.7%-3.8%, and a construction loan pipeline with $819M in unfunded commitments. Asset quality is excellent (zero non-performing loans reported) and capital is healthy. …
Diageo ($DEO) is delivering early signs of a recovery: brand-level wins in China, a clear premiumization runway, and technicals clustering around support. At a market cap near $50.9B and a current price of $91.16, the stock looks poised for a mid-term rebound if sales stabilize and margin actions continue. This article lays out a concrete trade pla…
Meta is trading at a lower multiple while free cash flow and profitability remain strong. AI-driven product improvements are already boosting engagement and ad yields. This trade targets a rally as markets re-price Meta for durable AI monetization, while respecting legal and regulatory tail risks.
Runway Growth Finance (RWAY) is a closed-end business development company offering senior secured loans to growth-stage tech and life sciences. The stock trades at roughly a 45% discount to estimated NAV, yields ~20% from a $0.33 quarterly distribution, and benefits from a recently completed SWK acquisition that expanded assets to $1.2B. We present…
Boise Cascade (BCC) is a cash-generative wood products and building materials distributor trading at a modest multiple, with an EV/EBITDA of 9.2, market cap of roughly $2.8B and free cash flow of $103M. The balance sheet is healthy, and housing-related end markets show improving fundamentals. We lay out a mid-term (45 trading days) long trade with …
Mercury General's recent underwriting recovery and strong cash generation compress downside risk while leaving room for share price re-rating. The company trades at a single-digit P/E and exhibits robust ROE and free cash flow - a classic value setup with definable catalysts and manageable balance-sheet risk.
Mainstreet Equity trades at an attractive entry after a period of sideways action. The company runs a portfolio of cash-generating businesses, and at $22.50 the risk/reward favors a long position: entry $22.50, stop $19.00, target $30.00 over the next 180 trading days.
H&R Block reported steady fiscal 2026 results (revenue $3.95B, adjusted net income $688M), repurchased nearly 8% of shares and raised its quarterly dividend to $0.46. With free cash flow of $760.9M, an EV/EBITDA of 6.75 and a P/E around 8.5-9x, the stock looks attractive for a mid-term long trade. I outline an entry at $50.95, stop at $46.00 and ta…
Micron is a fundamentally strong, cash-rich semiconductor that still trades with wide intraday swings and heavy options interest. That combination creates repeated opportunities to sell premium and establish defined-risk directional spreads. This trade uses a bullish 45-day call-spread plus a repeatable short-call selling plan to harvest theta whil…
SpaceX is one of the rare private companies that combines durable commercial launch demand, growing recurring revenue from Starlink, and strategic government contracts. Fundamentals are strong, but a near-term trade should respect valuation: this is a buy-on-dip setup rather than a buy-and-forget. I recommend a disciplined entry at $75.00 with a ti…
Palantir's Q2 momentum (reported ~93% revenue growth) and exceptional operating leverage make a compelling case that the market is underestimating the durability of its growth and margin profile. The stock is richly valued on headline multiples today, but near-term catalysts tied to sovereign AI adoption, expanding commercial footprints, and sustai…
Globus Medical has delivered seven consecutive quarters of margin expansion while continuing to grow revenue and generate strong free cash flow. The stock trades at $86.42 with a market cap near $11.6B and appears to underprice improving fundamentals and recent M&A. This is a long trade idea sized for disciplined risk seekers, with a clear entry, s…
<p>Capcom and Square Enix both sit on storied franchises and deep IP, but for investors the distinction between a great game company and a great investment can be material. This trade pairs a long position in Capcom with a short in Square Enix to capture valuation divergence, monetization strength, and differing capital allocation profiles. The pai…
